Methylphenidate and Remeron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Remeron (mirtazapine). Common drug interactions include pain among females and brain oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Remeron. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.

On Jul, 16, 2026

20 people who take Methylphenidate and Remeron together, and have interactions are studied.

Methylphenidate and Remeron drug interactions.

What are the common drug interactions of Methylphenidate and Remeron, by gender? *:

female:

Pain
Carpal tunnel decompression
Cataplexy (loss of muscle tone accompanied by full conscious awareness)
Chronic kidney disease
Colonoscopy
Constipation
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Emotional disorder
Eye disorder

male:

Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Drug abuse
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Periodic limb movement disorder
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Therapeutic response unexpected
Pulmonary oedema (fluid accumulation in the lungs)
Migraine (headache)

What are the common drug interactions of Methylphenidate and Remeron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Drug abuse
Pulmonary oedema (fluid accumulation in the lungs)
Drug ineffective

30-39:

Agitation (state of anxiety or nervous excitement)
Obesity (having too much body fat)
Sedation
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)

40-49:

n/a

50-59:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Hyperkalaemia (damage to or disease of the kidney)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Renal tubular necrosis (death of kidney tubules)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 45.00%
Overdose: 3 people, 15.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 15.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
Bone Disorder: 2 people, 10.00%
Stress And Anxiety: 1 person, 5.00%
Sleep Disorder: 1 person, 5.00%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 5.00%
Pain: 1 person, 5.00%
Inflammation: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Remeron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously